Ex Vivo Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ex Vivo Gene Therapy for Transfusion-Dependent Beta-Thalassemia, covering 2025-04-09 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy